Ignite Creation Date:
2024-05-06 @ 2:36 AM
Last Modification Date:
2024-10-26 @ 11:20 AM
Study NCT ID:
NCT02081053
Status:
TERMINATED
Last Update Posted:
2017-01-20
First Post:
2014-03-04
Brief Title:
Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty Also Known as Vertebral Augmentation to Treat Painful Metastatic Vertebral Body Tumors
Sponsor:
DFINE Inc
Organization:
Merit Medical Systems Inc
Study Overview
Official Title:
A Prospective Multicenter Clinical Study to Evaluate the Clinical Outcomes of Targeted Radiofrequency Ablation and Vertebral Augmentation to Treat Painful Metastatic Vertebral Body Tumors
Status:
TERMINATED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Difficulty Enrolling
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EU-STAR
Brief Summary:
To evaluate the clinical outcomes of minimally invasive targeted radiofrequency tumor ablation t-RFA and kyphoplasty also known as vertebral augmentation in painful metastatic lesions in the spine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None